Multiple endocrine neoplasia type 1: a review of current diagnostic and treatment approaches-Reference-Cited by-同舟云学术

Multiple endocrine neoplasia type 1: a review of current diagnostic and treatment approaches

Published:2020-09-01 Issue:9 Volume:8 Page:367-377
ISSN:2167-8707
Container-title:Expert Opinion on Orphan Drugs
language:en
Short-container-title:Expert Opinion on Orphan Drugs

Author:

Marini Francesca¹,Giusti Francesca¹,Tonelli Francesco¹,Brandi Maria Luisa¹

Affiliation:

1. Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Health Policy,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Link

https://www.tandfonline.com/doi/pdf/10.1080/21678707.2020.1811086

Reference59 articles.

1. Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)

2. National Library of Medicine. National Center for Biotechnology Information (NCBI); PubMed.gov website. [cited 2020 May]. https://pubmed.ncbi.nlm.nih.gov/

3. Online Mendelian Inheritance in Man (OMIM®). website; cited 2020 Aug 7. (Access date: May 2020). https://www.omim.org/entry/131100?search=MEN1&highlight=men1

4. Giusti F, Marini F, Brandi ML Multiple Endocrine Neoplasia Type 1. GeneReviews® [Internet], initial posting: August 31, 2005; cited 2017 Dec 14. (Access date: May 2020). https://www.ncbi.nlm.nih.gov/books/NBK1538/

5. Orphanet, the portal for rare diseases and orphan drugs. Orphanet version 5.39.0 - Last updated: 2020-08-10; [cited 2020 May]. https://www.orpha.net/consor/cgi-bin/Disease_Search.php?lng=EN&data_id=121&Disease_Disease_Search_diseaseGroup=MEN1&Disease_Disease_Search_diseaseType=Pat&Disease(s)/group%20of%20diseases=Multiple-endocrine-neoplasia-type-1&title=Multiple%20endocrine%20neoplasia%20type%201&search=Disease_Search_Simple

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pancreatic Neuroendocrine Neoplasms in Multiple Endocrine Neoplasia Type 1;International Journal of Molecular Sciences;2021-04-14

2. Rare cancers, the continued agenda for progress – editor’s special foreword;Expert Opinion on Orphan Drugs;2020-09-01